chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chronic hives since 2nd dose of Moderna vaccination. itching/hives all over body, From the top of my head to the tips of my toes. Heat causing body to have more of a rash/hives/itching. I also have dermatographia now. Zyrtec/Allegra helps control. Topical anti-itch barely helps, only for a few minutes. Ice packs help. Worse at night. Have been dealing with this for several months. No history of allergies/hives/eczema/anything like this before. Prednisone doses have helped (have done 2 rounds of this). PCP has referred me to dermatologist who has helped me figure this out finally. Will be seeing an allergist to help with the intense itching. Hoping they can do injections for the itching. Will not be taking the booster, cannot bear to deal with this itching any longer. This has been miserable. I have been up night crying, missed work, itching my skin off, hoping this will end soon.
G47.33 OBSTRUCTIVE SLEEP APNEA 3/2/2023 UTERINE FIBROIDS
pt had a positive COVID test on 1/16/22 and was hospitalized, (name of hospital not in records) for COVID pneumonia; 1/27/22 pt to ED via EMS with increasing SOB; DNI; pt had a positive COVID test in ED; pt placed on face mask ventilation; given IV steroids and bronchodilators; admitted to ICU; end stage COPD; worsening respiratory distress; family decided on comfort measures for pt and inpatient hospice on 2/6/22; pt passed away in the hospital
The patient experienced numbness on his face the day after the vaccine was administered which progressed to loss of functions of his right eyebrow. Pt was seen in ER 2 days after vaccine administered.
2nd dose given to a 3-year-old; Expired Pediarix administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 9X3T5, expiry date 05-MAR-2023) for prophylaxis.   On 07-MAR-2023, the patient received the 2nd dose of Pediarix. On 07-MAR-2023, an unknown time after receiving Pediarix, [the patient experienced inappropriate age at vaccine administration (Verbatim: 2nd dose given to a 3-year-old) and expired vaccine used (Verbatim: Expired Pediarix administered). The outcome of the inappropriate age at vaccine administration and expired vaccine used were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 07-MAR-2023  A nurse informed that earlier that day a patient went to receive the 2nd dose of Pediarix at inappropriate age, but the dose administered was expired, which led to inappropriate age at vaccine administration and expired vaccine used. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up
Patient is having trouble moving her injection site arm; injection site arm red; swollen arm; inability to concentrate; Dizziness; Fever of 103 Degrees Farenheight; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate) and DIZZINESS (Dizziness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concomitant products included ACETAMINOPHEN and IBUPROFEN for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate), DIZZINESS (Dizziness), PYREXIA (Fever of 103 Degrees Farenheight), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate), DIZZINESS (Dizziness), PYREXIA (Fever of 103 Degrees Farenheight), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 103 (High) 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details was reported.
Chills started just a few hours of the vaccine and I ran a fever for almost 24 hours. Left arm is still sore but getting better after 2 days.
Soreness in arm of injection; A spontaneous report was received from a non-health care professional concerning a 27 year old, male patient who experienced, soreness in arm of injection.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.    Prior to the onset of the symptom, on 22 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   The patient reported the event, soreness in arm of injection, on 23 Dec 2020 at 9:30 am.   Treatment information was not provided.   Action taken with mRNA-1273 in response to the event, soreness in arm of injection, was not reported.   The outcome of the event, was not reported.   The reporter did not provide assessments for the event, soreness in arm of injection.; Reporter's Comments: This case concerns a  27 year old male patient. The patient's medical history is not provided. The patient experienced an expected event of soreness in arm of injection. The event occurred on 23 Dec 2020, 1 day after  the first dose of mRNA-1273. The sponsor assessed the event as possibly related to the mRNA-1273 vaccine. Pain at the site of injection is listed on the company's fact sheet for the healthcare providers.
Itchy feeling that eventually resulted in a rash near the waistline. The rash started roughly 4 hours after being injected and resolved within 5 hours.
Patient passed out and fell on floor when walking out of the building 2 minutes after vaccine administration. After about 10 seconds he rolled onto his side and started to have convulsion-like movement for 5-10 seconds. He then woke up and asked "what happened" to him. EMS was called and he was treated by EMS. He appeared stable and declined transfer to hospital.
Approximately 57 hours after receiving 2nd dose of Pfizer vaccine, I developed hive patches throughout my body. I took 50 mg Benadryl and went to bed. Work up the next morning to observe some res spots, but minimal itching. I reported to work, where I am an EMT for an ambulance service. During shift, at approximately 1500 hours, I had a patient who was cold, so I cranked up the heat in the back of the ambulance. I started to sweat. My hive then came back with a vengeance all over my body. I immediately took 50 mg Benadryl and went to the urgent care center. The doctor told me to continue with the Benadryl and to pick up a prescription of Prednisone if symptoms worsen. Symptoms where mostly cleared up at that point. I got off shift at 1900. Hive worsened at approximately 2000. I picked up the prednisone and intend to begin taking it in the morning if symptoms are not much improved.
gotten 3 doses of Shingrix; This case was reported by a other health professional via interactive digital media and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date) and Shingrix (2nd dose received on an unknown date).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter thought that, the patient might have received 3rd dose of Shingrix, which led to extra dose administered.
3 days after the injection my left side itched and burned above my waste with  numbness and tingling a few days later starting get a rash kept getting worse and called the Dr office and found out i had shingles and put me on Valacyclovir 1 mg tab twice a day.  Was vaccinated for shingles about 8 years ago. But i have not gotten the new vaccine.
After the vaccine, the patient became dizzy/lightheaded in her chair. She moved to the floor. Vital signs monitored, initially not responsive once lowered to the ground. RN immediately called for a med kit, 911 called within the minute. History of pre-diabetes. O2 sats 96%, BP up to 200, elevated HR. The patient was withdrawing to pain, responding to sternal rub, did appear at one point to be gasping for air, and admin of 0.3 mg of epi was attempted but not given because it would not go in. AED unit was applied but no shock received. EMT arrived 10 min after called and the patient started to become more reactive, asking for her granddaughter. EKG administered and BP lowered to 130/80. The patient was taken to Hospital.
Information has been received from a physician concerning a 13-month-old male who on 23-AUG-2005 was vaccinated subcutaneously with a 0.5ml dose of varicella virus vaccine live (Oka/Merck) (lot # 651042/0214R). On 01-SEP-2005 the patient presented to the physician's office with a generalized itchy rash. The physician noted that the patient did not have a fever or malaise. At the time of this report the patient had not recovered. No further information available. No product quality complaint was involved. Additional information is not expected.
This spontaneous report as received from an unknown reporter via a field representative concerning a 12 month old male patient. No concurrent conditions, medical history or allergy/drug reactions were reported. On 25-APR-2016, the patient was vaccinated with one dose of VARIVAX lot #L025206 (dosing details, expiry date were not reported). On the same day, the patient experienced blisters and splotchy red rash. No treatment was given for the event. The patient did not seek any medical attention. The outcome of blisters and splotchy red rash was reported as recovered/resolved. The reporter did not provide the causality between the events and the suspect therapy. There were no product quality complaints (PQC) involved. Additional information is not expected as the reporter did not wish further contact.
Pt. completed Keflex 500 Q 12hr x 7 days @ 10/14/2019 for UTI. temp./fever checked prior to flu shot & temp 97.0 & felt cold 10/16/2019 even fever @ 101.7 & today 10/17 99.4
Bilateral carotid artery stenosis. Surgery and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Information has been received from a physician concerning a 6 year old female who on 30-OCT-2000 was vaccinated SC with a first dose of Varivax (lot # 634514/0539K). Concomitant vaccination on the same day included a dose of hepatitis B virus vaccine (lot # "635587/1092K"-invalid for this product). On 09-SEP-2006, the patient developed chickenpox. The patient recovered on an unspecified date. Additional information is not expected.
Splitting headache that I still get intermittently today; the headaches are not as frequent now but lasted 5 weeks straight. Severe joint pain and throbbing that lasted 1 day. Sensitive/prickly/painful skin/nerve pain that lasted 2 days. Injection site pain and stiffness that lasted 3 days. A week after 1st dose, I experienced lymph node pain in arm pit that lasted a week. I also experienced flu-like symptoms and body aches, as well as severe mouth/tooth pain a week after 1st dose that lasted a day.  About 12 days after 1st injection, I experienced left side ovary pain and spotting for over a week.
pt recvd vax; devel gen rash about 35;f/u indicated pt started to break out w/ chicken pox on 12jul95;at time of vax runny nose, mild cough & T 99;
This is a spontaneous report from a contactable consumer reporting for her daughter via a Pfizer sales representative. A 22-year-old female patient received the first dose of TRUMENBA, (lot M95612; expiry date Jul2017), via an unspecified route of administration at 0.5 ml, single in the left arm on 13Aug2016 at 11:40 am for immunisation. Medical history included possible allergy to KEFLEX. There were no concomitant medications. The patient experienced red splotchy hives all down both of her arms to about elbow, as well as under her neck and across her chest/hives on 13Aug2016 at 12:40 but the hives went away after an hour without any treatment. On 16Aug2016 in the area where shot was given that was a red bullseye from which she recovered on an unspecified date in 2016 without treatment and on an unspecified day in Aug2016 she had red hot on the neck, chest and arm for which was treated and recovered an unspecified date in 2016. Follow-up (25Oct2016): New information reported from the same contactable consumer includes: suspect vaccine details (lot, expiry date), updated events outcome, details on treatment. Follow-up attempts are completed. No further information is expected.
This case was reported by a nurse and described the occurrence of threw up in a 3-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical conditions included reflux (unknown). Concurrent vaccination included PEDIARIX (GlaxoSmithKline; unknown route and injection site), ACTHIB (non-gsk) (Sanofi; unknown route and injection site) and PREVNAR 13 (non-gsk) (Wyeth Labs; unknown route and injection site), all given on 16 July 2014. On 16 July 2014, the subject received 1st dose of ROTARIX (1 ml, oral). On 16 July 2014, immediately after vaccination with ROTARIX, the subject experienced threw up. At the time of reporting, the outcome of the event was unspecified. The nurse considered the event was unrelated to vaccination with ROTARIX because the infant had reflux.
Headache, Myalgia, Diarrhea, FATIGUE, CHILLS, WEAKNESS Narrative:
phlegm; sinuses; I got my 1st dose on Mar20th. Two weeks later I tested positive for Covid; I got my 1st dose on Mar20th. Two weeks later I tested positive for Covid; This is a spontaneous report from contactable consumer (patient) from a Pfizer-sponsored program. A 51-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number: EP6955 and expiry: unknown), via an unspecified route of administration, in the right arm, on 20Mar2021 (at the age of 52-years-old) as a single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. On 02Apr2021, two weeks later patient tested positive for Covid. On unknown date patient experienced phlegm and sinuses. Treatment received was decongestant as loratadine (CLARITIN D) or guaifenesin pseudoephedrine hydrochloride (MUCINEX D) for phlegm and sinuses. Patient wants to know when and if she can get 2nd dose. The outcome of events was unknown.
Fatigue; Fever; Itchy body; Chills; Lower back pain; This case was reported by a pharmacist and described the occurrence of fatigue in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 9H524, expiry date unknown) for prophylaxis.   On 18th January 2020, the patient received the 1st dose of Shingrix. On 18th January 2020, less than a day after receiving Shingrix, the patient experienced fatigue, fever, generalized pruritus, chills and low back pain. On an unknown date, the outcome of the fatigue, fever, generalized pruritus, chills and low back pain were recovered/resolved.   It was unknown if the reporter considered the fatigue, fever, generalized pruritus, chills and low back pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix, and experienced fatigue, chills, itchy body, fever and lower back pain. This case was linked with US2020AMR242120, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR242120:Same reporter. Case for dose 2
I developed a Blood Clot in My Artery in my right leg. Dr's could not officially diagnose why the blood clot happened by my blood tests.  I asked them if it could have been caused by my booster shot and they told me they could not say but it was unlikely but that I should report it anyways.
Pain and  and severe weakness in arms and legs. Joint pain. Numbness in feet and hands. Increased blood pressure.
SubQ; This spontaneous case was reported by a physician and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (SubQ) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included Stent placement (Cardiac stint) on 07-Jan-2017. Concurrent medical conditions included Asthma since 01-Jan-1950, Arthritis since 01-Jan-2006, Depression (Major depression) since 01-Jan-1980, Type II diabetes mellitus since 01-Jan-2000 and Drug allergy (Ca++ channel blockers). Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) from 01-Jan-2010 to an unknown date for Asthma, CITALOPRAM from 01-Jan-1987 to an unknown date for Depression, METFORMIN HYDROCHLORIDE (METFORMIN [METFORMIN HYDROCHLORIDE]) from 01-Jan-2010 to an unknown date, GLIMEPIRIDE from 01-Jan-2015 to an unknown date and INSULIN HUMAN INJECTION, ISOPHANE (NOVOLIN N) from 01-Jan-2010 to an unknown date for Diabetes.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 01-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (SubQ). On 01-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (SubQ) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that second injection of vaccine was less painful than the first.   No treatment medication reported   This case was linked to MOD-2021-031651, MOD-2021-032479, US-MODERNATX, INC.-MOD-2021-032479 (E2B Linked Report). This case was linked to MOD-2021-032594, MOD-2021-032594 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Concomitant medication list updated, medical history was updated; Sender's Comments:  MOD-2021-031651:Crosslinked case: Wife case (1st dose) MOD-2021-032479:Crosslinked case: Wife case (2nd dose) US-MODERNATX, INC.-MOD-2021-032479:Crosslinked case: Same reporter/different patient (husband)
Started with fussiness and runny nose, then red blisters started to appear on his face around his mouth and on his forehead. Over the next two days the blisters appeared on his trunk and groin and extremities. Fever up to 101.5. He continues to exhibit symptoms and we may take him to the doctor if they persist or increase.
Sore right arm, aching, discomfort.  Lose of strength in right arm.
Five minutes after administration, patient states arm felt numb and tingled.  Ten minutes later she felt pain and tingle in fingers.  After 45 minutes patient has soreness on hand and palm
According to Occupational Health Nurse and a incident report, patient reported he received a flu vaccine on the morning of 10-26-06; on 10-27-06 he began to experience a mild reaction of fever and hives; on 10-28-06, these symptoms increased in severity, which sent him to be seen at the doctors. He was seen, treated, and released with medication from a doctor. He has had a flu recovery to his pre-vaccine state.
mom states couple of hr p/vax given, broke out in hives;states both arms red & swollen the rt arm worse
high temperature; headaches; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches), NAUSEA (nausea), FATIGUE (fatigue) and PYREXIA (high temperature) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Cancer. Concomitant products included METFORMIN for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced HEADACHE (headaches), NAUSEA (nausea) and FATIGUE (fatigue). On 03-Mar-2021, the patient experienced PYREXIA (high temperature). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 04-Mar-2021, PYREXIA (high temperature) had resolved. On 05-Mar-2021, HEADACHE (headaches), NAUSEA (nausea) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes blood pressure medication,diabetes medication, metformin.
Pt came to pharmacy 10/3/14 - large (about 4" x 6") raised bruised area on (L) arm. She stated was reaction to flu shot. Pt. then went to doctor and was told it was really bad bruise but would be OK.
Rash at injection site, arthralgia of multiple joints, anorexia, malaise.
Feeling disoriented and dizzy within about 2 hours. Severe swelling at vaccination site within 12 hours, with skin very hot to touch for about one week. High fever (over 102 in patient with normal temp of less than 98.6) within about 4 hours lasting about 30 hours. Patient took Benadryl and ibuprofen after contacting physician's office the next morning.
Got tested on 4/26/2021 as they were schedule for pre-operation. Fully asymptomatic.
lymph nodes in my neck on left side became swollen, injection site was hard and started with pain and an eraser size reaction, the following day my injection site developed a rash larger than a quarter with under arm axillary pain, that night the rash was raised, today rash is the size of a tennis ball is warm to touch, neck lymph node is going down, today I have taken Benadryl.
Took Covid vaccine February 28, 2021, lack of sleep that night and next 2 nights. On March 3, 2021, about 12:30 am was sleepwalking until 7 am next morning. Kept getting up and going to bed about ever 10 to 15 minutes. Fell on his back once but did not wake up. Next morning (9 am), March 4, 2021, had bad taste in mouth.  Rinsed mouth with mouthwash which helped. Was not hungry for breakfast. went back to bed at 10 am. got up at 10:30 am and said he felt bloated. gave him Pepto Bismol  and he went back to bed. Slept approximately 3 hours. Ate soup and sandwich with no problem. was alert and at 100%. Said he felt good and didn't remember anything from previous night.
developed more severe arm pain, headache, rigors, muscle aches- lasted approx 3 -4 hour- took tylenol, used heating pad